Global Market Development Manager - Molecular Biology Business
Waltham, Ma, Us
Led cross-functional teams, built strong working relationships and advanced meaningful and strategic customer relationships with KOL’s Internationally across the Molecular Biology Business Segment with major International Research Consortia and Collaborative “Big Science” Programs: Business focus Affinity Reagents and Clinical Proteomics, Next Generation Sequencing (NGS), Clinical Genomics, Epigenetics and Stem Cells. Provided strategic input into the company’s business development activities and effectively conveyed recommendations to senior Executive leadership, led internal and external discussions with key stakeholders, and fostered executive level relationships with Major International Funding Agencies and Industry, working through a matrix report structure with Executive VP’s Molecular Biology Business Segment; R&D, Commercial Sales and Marketing. Created an effective innovation pipeline by developing Life Technologies’ scientific collaborations, and proprietary technology seeding into strategic growth sectors including:• Novel methodologies and advanced reagents for Pharmacogenomics, NGS and targeted medical re-sequencing• Preferred “scientific relationship” with the International Human Proteome Organization (HUPO); development of HUPO Proteomic Standards, Scientific Initiatives and Industrial Advisory Board (IAB)• Clinical Affinity Proteomics; International Ab Reagent programs, advanced MS instrumentation• International Stem Cell research programs; Canadian Stem Cell Network, International Stem Cell Regulome project (IRC), Asian Stem Cell Proteomics Initiatives (S.Korea, Japan), developing EU programs including Welcome Trust• Emerging Next Gen Genomics programs including: I-Bol - the International DNA Barcode Project, Phase II of the Structural Genomics Consortia (SGC), The International Human Microbiome Project